Is Rituximab Approved in Pediatric Non Hodgkin Lymphoma?

被引：0
|
作者：
Linga, Vijay Gandhi [1 ]
Digumati, Raghunadharao [1 ]
机构：
[1] Nizams Inst Med Sci, Dept Med Oncol, Hyderabad, Andhra Pradesh, India
来源：
INDIAN PEDIATRICS | 2012年 / 49卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [1] Pediatric non-Hodgkin lymphoma
    Gross T.G.
    Termuhlen A.M.
    Current Hematologic Malignancy Reports, 2008, 3 (3) : 167 - 173
  • [2] Rituximab in the treatment of non-Hodgkin's lymphoma
    Hauptrock, Beate
    Hess, Georg
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 619 - 633
  • [3] RITUXIMAB CLEARANCE IN PEDIATRIC PATIENTS WITH MAATURE B-CELL NON-HODGKIN LYMPHOMA
    Toelle, I.
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfing, M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    LEUKEMIA RESEARCH, 2022, 121 : S23 - S24
  • [4] Rituximab immunotherapy for non-Hodgkin's lymphoma
    White, CA
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (04) : 241 - 250
  • [5] RITUXIMAB INDUCES HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH NON HODGKIN LYMPHOMA
    Della Pepa, R.
    Spadaro, G.
    Luponio, S.
    Giagnuolo, G.
    Beneduce, G.
    Migliaccio, I.
    Raimondo, M.
    Cimmino, C.
    Pane, F.
    De Renzo, A.
    HAEMATOLOGICA, 2015, 100 : 154 - 154
  • [6] Rituximab for the therapy of non-Hodgkin's lymphoma
    Rummel, M. J.
    ONKOLOGE, 2007, 13 (03): : 227 - +
  • [7] RITUXIMAB FOR NON HODGKIN LYMPHOMA: OVERVIEW OF EFFICACY AND SAFETY
    Costa, J. O.
    Lemos, L. L. P.
    Junior, A. A. G.
    Acurcio, F. A.
    VALUE IN HEALTH, 2013, 16 (03) : A128 - A128
  • [8] RITUXIMAB INDUCES HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH NON HODGKIN LYMPHOMA
    Della Pepa, R.
    De Renzo, A.
    Pecoraro, A.
    Luponio, S.
    Giagnuolo, G.
    Beneduce, G.
    Migliaccio, I.
    Raimondo, M.
    Pugliese, N.
    Salvatore, D.
    Cimmino, C.
    Pane, F.
    Spadaro, G.
    HAEMATOLOGICA, 2015, 100 : 709 - 710
  • [9] Treatment approach for non-Hodgkin lymphoma patients since first biosimilars of rituximab approved in EU5.
    Franceschetti, Alessandra
    Caldeira, Rita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma
    Toelle, I
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfi, Ng M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 203 - 203
12345